Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Unit Trust
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: South Korea

Dongbu Bio-Health Care Securities Investment Trust 1 - Equity

+ Add to Watchlist

6170161:KS

1,239.08 KRW 7.00 0.57%

As of 14:31:42 ET on 05/22/2015.

Snapshot for Dongbu Bio-Health Care Securities Investment Trust 1 - Equity (6170161)

Year To Date: - 3-Month: - 3-Year: +18.79% 52-Week Range: 995.70 - 1,239.08
1-Month: +5.99% 1-Year: - 5-Year: - Beta vs KOSPI: -

Mutual Fund Chart for 6170161

No chart data available.
  • 6170161:KS 1,239.08
  • 1M
  • 1Y
Interactive 6170161 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for 6170161

Dongbu Bio-Health Care Securities Investment Trust 1 (Equity) is an open-end fund incorporated in South Korea. The Fund's objective is to achieve capital gains and current income. The Fund invests at least 50% of its total assets in Bio-Health Care stocks.

Inception Date: 01-18-2012 Telephone: 82-2-787-3700
Managers: YONG-NAM HAN
Web Site: www.dongbuam.co.kr

Fundamentals for 6170161

NAV (on 2015-05-22) 1,239.08
Assets (M) (on 2015-05-22) 173,553.19
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for 6170161

Dividend Type Omitted
Dividend Frequency Annual
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for 6170161

Front Load -
Back Load -
Current Mgmt Fee 0.72
Redemption Fee -
12b1 Fee -
Expense Ratio 0.81

Top Fund Holdings for 6170161

Filing Date: 12/31/2014
Name Position Value % of Total
HLB Inc 189,337 1,457,894,900 8.581%
InBody Co Ltd 28,979 912,838,500 5.373%
Naturalendo Tech Co Ltd 19,244 876,564,200 5.159%
JVM Co Ltd 14,261 857,086,100 5.045%
Vieworks Co Ltd 22,674 777,718,200 4.577%
Chong Kun Dang Pharmaceutical 10,889 711,051,700 4.185%
CTC BIO Inc 37,680 644,328,000 3.792%
Huvitz Co Ltd 36,434 615,734,600 3.624%
Chongkundang Holdings Corp 9,951 595,069,800 3.502%
Devsisters Co Ltd 11,927 569,514,250 3.352%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil